Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *British journal of cancer

Results: 1-25/859

Authors: Heidtmann, HH Nettelbeck, DM Mingels, A Jager, R Welker, HG Kontermann, RE
Citation: Hh. Heidtmann et al., Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen, BR J CANC, 81(8), 1999, pp. 1269-1273

Authors: Tomozawa, S Nagawa, H Tsuno, N Hatano, K Osada, T Kitayama, J Sunami, E Nita, ME Ishihara, S Yano, H Tsuruo, T Shibata, Y Muto, T
Citation: S. Tomozawa et al., Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522, BR J CANC, 81(8), 1999, pp. 1274-1279

Authors: Chao, D Bahl, P Houlbrook, S Hoy, L Harris, AL Austyn, JM
Citation: D. Chao et al., Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay, BR J CANC, 81(8), 1999, pp. 1280-1284

Authors: te Poele, RH Joel, SP
Citation: Rh. Te Poele et Sp. Joel, Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colonadenocarcinoma cell lines, BR J CANC, 81(8), 1999, pp. 1285-1293

Authors: O'Neill, CF Koberle, B Masters, JRW Kelland, LR
Citation: Cf. O'Neill et al., Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin, BR J CANC, 81(8), 1999, pp. 1294-1303

Authors: Vanhoefer, U Muller, MR Hilger, RA Lindtner, B Klaassen, U Schleucher, N Rustum, YM Seeber, S Harstrick, A
Citation: U. Vanhoefer et al., Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines, BR J CANC, 81(8), 1999, pp. 1304-1310

Authors: Pidgeon, GP Harmey, JH Kay, E Da Costa, M Redmond, HP Bouchier-Hayes, DJ
Citation: Gp. Pidgeon et al., The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease, BR J CANC, 81(8), 1999, pp. 1311-1317

Authors: Grosios, K Holwell, SE McGown, AT Pettit, GR Bibby, MC
Citation: K. Grosios et al., In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug, BR J CANC, 81(8), 1999, pp. 1318-1327

Authors: Forozan, F Veldman, R Ammerman, CA Parsa, NZ Kallioniemi, A Kallioniemi, OP Ethier, SP
Citation: F. Forozan et al., Molecular cytogenetic analysis of 11 new breast cancer cell lines, BR J CANC, 81(8), 1999, pp. 1328-1334

Authors: Xie, B Tam, NNC Tsao, SW Wong, YC
Citation: B. Xie et al., Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat, BR J CANC, 81(8), 1999, pp. 1335-1343

Authors: Le Pimpec-Barthes, F Bernard, I Abd Alsamad, I Renier, A Kheuang, L Fleury-Feith, J Devauchelle, P Colonna, FQ Riquet, M Jaurand, MC
Citation: F. Le Pimpec-barthes et al., Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells, BR J CANC, 81(8), 1999, pp. 1344-1350

Authors: Mitry, E Baudin, E Ducreux, M Sabourin, JC Rufie, P Aparicio, T Lasser, P Elias, D Duvillard, P Schlumberger, M Rougier, P
Citation: E. Mitry et al., Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin, BR J CANC, 81(8), 1999, pp. 1351-1355

Authors: Langman, MJS Dunn, JA Whiting, JL Burton, A Hallissey, MT Fielding, JWL Kerr, DJ
Citation: Mjs. Langman et al., Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer, BR J CANC, 81(8), 1999, pp. 1356-1362

Authors: Wester, K Ranefall, P Bengtsson, E Busch, C Malmstrom, PU
Citation: K. Wester et al., Automatic quantification of microvessel density in urinary bladder carcinoma, BR J CANC, 81(8), 1999, pp. 1363-1370

Authors: Balesaria, S Brock, C Bower, M Clark, J Nicholson, SK Lewis, P de Sanctis, S Evans, H Peterson, D Mendoza, N Glaser, MG Newlands, ES Fisher, RA
Citation: S. Balesaria et al., Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas, BR J CANC, 81(8), 1999, pp. 1371-1377

Authors: Garaventa, A Bellagamba, O Lo Piccolo, MS Milanaccio, C Lanino, E Bertolazzi, L Villavecchia, GP Cabria, M Scopinaro, G Claudiani, F De Bernardi, B
Citation: A. Garaventa et al., I-131-metaiodobenzylguanidine (I-131-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients, BR J CANC, 81(8), 1999, pp. 1378-1384

Authors: Scorilas, A Trangas, T Yotis, J Pateras, C Talieri, M
Citation: A. Scorilas et al., Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis, BR J CANC, 81(8), 1999, pp. 1385-1391

Authors: Ramesh, S Nash, J McCulloch, PG
Citation: S. Ramesh et al., Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer, BR J CANC, 81(8), 1999, pp. 1392-1397

Authors: Pruneri, G Bertolini, F Soligo, D Carboni, N Cortelezzi, A Ferrucci, PF Buffa, R Lambertenghi-Deliliers, G Pezzella, F
Citation: G. Pruneri et al., Angiogenesis in myelodysplastic syndromes, BR J CANC, 81(8), 1999, pp. 1398-1401

Authors: Abel, F Ejeskar, K Kogner, P Martinsson, T
Citation: F. Abel et al., Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24, BR J CANC, 81(8), 1999, pp. 1402-1409

Authors: Vos, CBJ ter Haar, NT Rosenberg, C Peterse, JL Cleton-Jansen, AM Cornelisse, CJ van de Vijver, MJ
Citation: Cbj. Vos et al., Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type, BR J CANC, 81(8), 1999, pp. 1410-1418

Authors: Tokuda, Y Watanabe, T Omuro, Y Ando, M Katsumata, N Okumura, A Ohta, M Fujii, H Sasaki, Y Niwa, T Tajima, T
Citation: Y. Tokuda et al., Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer, BR J CANC, 81(8), 1999, pp. 1419-1425

Authors: Thornton, H Baum, M
Citation: H. Thornton et M. Baum, Mammographic compression: a force to be reckoned with - reply, BR J CANC, 81(8), 1999, pp. 1426-1427

Authors: van Netten, JP Cann, SA Glover, DW
Citation: Jp. Van Netten et al., Mammographic compression: a force to be reckoned with, BR J CANC, 81(8), 1999, pp. 1426-1426

Authors: Stehle, G Wunder, A Hartung, G Sinn, H Heene, DL
Citation: G. Stehle et al., Prognostic value of cathepsin D in breast cancer, BR J CANC, 81(8), 1999, pp. 1427-1428
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>